Edition:
United States

Profile: Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

210.00USD
4:01pm EDT
Change (% chg)

$-5.00 (-2.33%)
Prev Close
$215.00
Open
$211.74
Day's High
$214.12
Day's Low
$208.94
Volume
795,354
Avg. Vol
499,650
52-wk High
$256.78
52-wk Low
$184.58

Allergan plc is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter pharmaceutical products. The Company operates through three segments: US Specialized Therapeutics, US General Medicine and International. The US Specialized Therapeutics segment includes sales relating to branded products within the United States, including Medical Aesthetics, Medical Dermatology, Eye Care, Neurosciences and Urology therapeutic products. The US General Medicine segment includes sales relating to branded products within the United States that do not fall into the US Specialized Therapeutics business units, including Central Nervous System, Gastrointestinal, Women's Health, Anti-Infectives and Diversified Brands. The International segment includes sales relating to products sold outside the United States.

Company Address

Allergan plc

Clonshaugh Business And Technolo
Coolock
DUBLIN     D17 E400
P: +35321.65235000

Company Web Links